Sunitinib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.
about
Sunitinib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Sunitinib combined with transa ...... opensity score matching study.
@en
Sunitinib combined with transa ...... opensity score matching study.
@nl
type
label
Sunitinib combined with transa ...... opensity score matching study.
@en
Sunitinib combined with transa ...... opensity score matching study.
@nl
prefLabel
Sunitinib combined with transa ...... opensity score matching study.
@en
Sunitinib combined with transa ...... opensity score matching study.
@nl
P2093
P2860
P1433
P1476
Sunitinib combined with transa ...... opensity score matching study.
@en
P2093
P2860
P2888
P304
P356
10.1007/S13277-014-2608-3
P577
2014-09-14T00:00:00Z